NCT05829057 2024-02-13The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1Zhejiang UniversityPhase 1 Unknown10 enrolled
NCT05429866 2023-03-08Immunological Variables Associated to ICI Toxicity in Cancer PatientsJules Bordet InstitutePhase 2 Unknown441 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled
NCT03076372 2018-02-27A Study Evaluating MM-310 in Patients With Solid TumorsMerrimack PharmaceuticalsPhase 1 Unknown34 enrolled
NCT02577627 2017-04-04Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOCOptimata Ltd.Unknown5,000 enrolled
NCT01242072 2012-07-18Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesAlaunos TherapeuticsPhase 1 Unknown12 enrolled